pVHL Function Is Essential for Endothelial Extracellular Matrix Deposition

REFERENCES

• Abbott, B. D., and A. R. Buckalew. 2000. Placental defects in ARNT-knockout conceptus correlate with localized decreases in VEGF-R2, Ang-1, and Tie-2. Dev. Dyn. 219:526–538.
   PubMedGoogle Scholar
• Adelman, D. M., M. Gertsenstein, A. Nagy, M. C. Simon, and E. Maltepe. 2000. Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev. 14:3191–3203.
   PubMed Web of Science ®Google Scholar
• Adryan, B., H. J. Decker, T. S. Papas, and T. Hsu. 2000. Tracheal development and the von Hippel-Lindau tumor suppressor homolog in Drosophila. Oncogene 19:2803–2811.
   PubMedGoogle Scholar
• Alexander, J. S., and J. W. Elrod. 2002. Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation. J. Anat. 200:561–574.
   PubMed Web of Science ®Google Scholar
• Bishop, T., K. W. Lau, A. C. Epstein, S. K. Kim, M. Jiang, D. O'Rourke, C. W. Pugh, J. M. Gleadle, M. S. Taylor, J. Hodgkin, and P. J. Ratcliffe. 2004. Genetic analysis of pathways regulated by the von Hippel-Lindau tumor suppressor in Caenorhabditis elegans. PLoS Biol. 2:e289.
   PubMedGoogle Scholar
• Bruick, R. K., and S. L. McKnight. 2001. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294:1337–1340.
   PubMed Web of Science ®Google Scholar
• Cohen, H. T., M. Zhou, A. M. Welsh, S. Zarghamee, H. Scholz, D. Mukhopadhyay, T. Kishida, B. Zbar, B. Knebelmann, and V. P. Sukhatme. 1999. An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-association. Biochem. Biophys. Res. Commun. 266:43–50.
   PubMedGoogle Scholar
• Coulet, F., S. Nadaud, M. Agrapart, and F. Soubrier. 2003. Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J. Biol. Chem. 278:46230–46240.
   PubMedGoogle Scholar
• Defilippi, P., C. Olivo, M. Venturino, L. Dolce, L. Silengo, and G. Tarone. 1999. Actin cytoskeleton organization in response to integrin-mediated adhesion. Microsc. Res. Tech. 47:67–78.
   PubMed Web of Science ®Google Scholar
• Duan, D. R., A. Pause, W. H. Burgess, T. Aso, D. Y. Chen, K. P. Garrett, R. C. Conaway, J. W. Conaway, W. M. Linehan, and R. D. Klausner. 1995. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269:1402–1406.
   PubMed Web of Science ®Google Scholar
• Duan, L. J., Y. Zhang-Benoit, and G. H. Fong. 2005. Endothelium-intrinsic requirement for Hif-2α during vascular development. Circulation 111:2227–2232.
   PubMedGoogle Scholar
• Engbring, J. A., and H. K. Kleinman. 2003. The basement membrane matrix in malignancy. J. Pathol. 200:465–470.
   PubMed Web of Science ®Google Scholar
• Epstein, A. C., J. M. Gleadle, L. A. McNeill, K. S. Hewitson, J. O'Rourke, D. R. Mole, M. Mukherji, E. Metzen, M. I. Wilson, A. Dhanda, Y. M. Tian, N. Masson, D. L. Hamilton, P. Jaakkola, R. Barstead, J. Hodgkin, P. H. Maxwell, C. W. Pugh, C. J. Schofield, and P. J. Ratcliffe. 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43–54.
   PubMed Web of Science ®Google Scholar
• Esteban-Barragan, M. A., P. Avila, M. Alvarez-Tejado, M. D. Gutierrez, A. Garcia-Pardo, F. Sanchez-Madrid, and M. O. Landazuri. 2002. Role of the von Hippel-Lindau tumor suppressor gene in the formation of beta1-integrin fibrillar adhesions. Cancer Res. 62:2929–2936.
   PubMed Web of Science ®Google Scholar
• Francis, S. E., K. L. Goh, K. Hodivala-Dilke, B. L. Bader, M. Stark, D. Davidson, and R. O. Hynes. 2002. Central roles of α5β1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler. Thromb. Vasc. Biol. 22:927–933.
   PubMed Web of Science ®Google Scholar
• George, E. L., H. S. Baldwin, and R. O. Hynes. 1997. Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. Blood 90:3073–3081.
   PubMed Web of Science ®Google Scholar
• George, E. L., E. N. Georges-Labouesse, R. S. Patel-King, H. Rayburn, and R. O. Hynes. 1993. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119:1079–1091.
   PubMed Web of Science ®Google Scholar
• Gnarra, J. R., J. M. Ward, F. D. Porter, J. R. Wagner, D. E. Devor, A. Grinberg, M. R. Emmert-Buck, H. Westphal, R. D. Klausner, and W. M. Linehan. 1997. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc. Natl. Acad. Sci. USA 94:9102–9107.
   PubMed Web of Science ®Google Scholar
• Gnarra, J. R., S. Zhou, M. J. Merrill, J. R. Wagner, A. Krumm, E. Papavassiliou, E. H. Oldfield, R. D. Klausner, and W. M. Linehan. 1996. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc. Natl. Acad. Sci. USA 93:10589–10594.
   PubMed Web of Science ®Google Scholar
• Haas, T. L., and J. A. Madri. 1999. Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: implications for angiogenesis. Trends Cardiovasc. Med. 9:70–77.
   PubMed Web of Science ®Google Scholar
• Haase, V. H., J. N. Glickman, M. Socolovsky, and R. Jaenisch. 2001. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc. Natl. Acad. Sci. USA 98:1583–1588.
   PubMed Web of Science ®Google Scholar
• Ilic, D., B. Kovacic, K. Johkura, D. D. Schlaepfer, N. Tomasevic, Q. Han, J. B. Kim, K. Howerton, C. Baumbusch, N. Ogiwara, D. N. Streblow, J. A. Nelson, P. Dazin, Y. Shino, K. Sasaki, and C. H. Damsky. 2004. FAK promotes organization of fibronectin matrix and fibrillar adhesions. J. Cell Sci. 117:177–187.
   PubMed Web of Science ®Google Scholar
• Ilic, D., B. Kovacic, S. McDonagh, F. Jin, C. Baumbusch, D. G. Gardner, and C. H. Damsky. 2003. Focal adhesion kinase is required for blood vessel morphogenesis. Circ. Res. 92:300–307.
   PubMed Web of Science ®Google Scholar
• Iliopoulos, O., A. P. Levy, C. Jiang, W. G. Kaelin, Jr., and M. A. Goldberg. 1996. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA 93:10595–10599.
   PubMed Web of Science ®Google Scholar
• Jain, R. K. 2003. Molecular regulation of vessel maturation. Nat. Med. 9:685–693.
   PubMed Web of Science ®Google Scholar
• Kaelin, W. G., Jr. 2002. Molecular basis of the VHL hereditary cancer syndrome. Nat. Rev. Cancer 2:673–682.
   PubMed Web of Science ®Google Scholar
• Kaelin, W. G., Jr. 2004. The von Hippel-Lindau tumor suppressor gene and kidney cancer. Clin. Cancer Res. 10:6290S–5S.
   PubMed Web of Science ®Google Scholar
• Kalluri, R. 2003. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer 3:422–433.
   PubMed Web of Science ®Google Scholar
• Kibel, A., O. Iliopoulos, J. A. DeCaprio, and W. G. Kaelin, Jr. 1995. Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C. Science 269:1444–1446.
   PubMed Web of Science ®Google Scholar
• Kisanuki, Y. Y., R. E. Hammer, J. Miyazaki, S. C. Williams, J. A. Richardson, and M. Yanagisawa. 2001. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 230:230–242.
   PubMed Web of Science ®Google Scholar
• Mack, F. A., W. K. Rathmell, A. M. Arsham, J. Gnarra, B. Keith, and M. C. Simon. 2003. Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth. Cancer Cell 3:75–88.
   PubMed Web of Science ®Google Scholar
• Maher, E. R., and W. G. Kaelin, Jr. 1997. von Hippel-Lindau disease. Medicine (Baltimore) 76:381–391.
   PubMed Web of Science ®Google Scholar
• Maxwell, P. H., M. S. Wiesener, G. W. Chang, S. C. Clifford, E. C. Vaux, M. E. Cockman, C. C. Wykoff, C. W. Pugh, E. R. Maher, and P. J. Ratcliffe. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271–275.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay, D., B. Knebelmann, H. T. Cohen, S. Ananth, and V. P. Sukhatme. 1997. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol. Cell. Biol. 17:5629–5639.
   PubMed Web of Science ®Google Scholar
• Ohh, M., and W. G. Kaelin, Jr. 1999. The von Hippel-Lindau tumor suppressor protein: new perspectives. Mol. Med. Today 5:257–263.
   PubMedGoogle Scholar
• Ohh, M., C. W. Park, M. Ivan, M. A. Hoffman, T. Y. Kim, L. E. Huang, N. Pavletich, V. Chau, and W. G. Kaelin. 2000. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2:423–427.
   PubMed Web of Science ®Google Scholar
• Ohh, M., R. L. Yauch, K. M. Lonergan, J. M. Whaley, A. O. Stemmer-Rachamimov, D. N. Louis, B. J. Gavin, N. Kley, W. G. Kaelin, Jr., and O. Iliopoulos. 1998. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol. Cell 1:959–968.
   PubMed Web of Science ®Google Scholar
• Pal, S., K. P. Claffey, H. F. Dvorak, and D. Mukhopadhyay. 1997. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways. J. Biol. Chem. 272:27509–27512.
   PubMed Web of Science ®Google Scholar
• Pompe, T., F. Kobe, K. Salchert, B. Jorgensen, J. Oswald, and C. Werner. 2003. Fibronectin anchorage to polymer substrates controls the initial phase of endothelial cell adhesion. J. Biomed. Mater. Res. 67A:647–657.
   Google Scholar
• Regnault, V., C. Rivat, and J. F. Stoltz. 1988. Affinity purification of human plasma fibronectin on immobilized gelatin. J. Chromatogr. 432:93–102.
   PubMed Web of Science ®Google Scholar
• Robinson, E. E., R. A. Foty, and S. A. Corbett. 2004. Fibronectin matrix assembly regulates α5β1-mediated cell cohesion. Mol. Biol. Cell 15:973–981.
   PubMed Web of Science ®Google Scholar
• Ryan, H. E., J. Lo, and R. S. Johnson. 1998. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17:3005–3015.
   PubMed Web of Science ®Google Scholar
• Siemeister, G., K. Weindel, K. Mohrs, B. Barleon, G. Martiny-Baron, and D. Marme. 1996. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res 56:2299–2301.
   PubMed Web of Science ®Google Scholar
• Sinor, A. D., S. M. Irvin, C. S. Cobbs, J. Chen, S. H. Graham, and D. A. Greenberg. 1998. Hypoxic induction of vascular endothelial growth factor (VEGF) protein in astroglial cultures. Brain Res. 812:289–291.
   PubMedGoogle Scholar
• Stebbins, C. E., W. G. Kaelin, Jr., and N. P. Pavletich. 1999. Structure of the VHL-elonginC-elonginB complex: implications for VHL tumor suppressor function. Science 284:455–461.
   PubMed Web of Science ®Google Scholar
• Stickle, N. H., J. Chung, J. M. Klco, R. P. Hill, W. G. Kaelin, Jr., and M. Ohh. 2004. pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development. Mol. Cell. Biol. 24:3251–3261.
   PubMedGoogle Scholar
• Tallquist, M. D., and P. Soriano. 2000. Epiblast-restricted Cre expression in MORE mice: a tool to distinguish embryonic versus extra-embryonic gene function. Genesis 26:113–115.
   PubMedGoogle Scholar
• Tang, N., L. Wang, J. Esko, F. J. Giordano, Y. Huang, H. P. Gerber, N. Ferrara, and R. S. Johnson. 2004. Loss of HIF-1α in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 6:485–495.
   PubMed Web of Science ®Google Scholar
• Tian, H., S. L. McKnight, and D. W. Russell. 1997. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11:72–82.
   PubMed Web of Science ®Google Scholar
• Wu, M. H., E. Ustinova, and H. J. Granger. 2001. Integrin binding to fibronectin and vitronectin maintains the barrier function of isolated porcine coronary venules. J. Physiol. 532:785–791.
   PubMed Web of Science ®Google Scholar